These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1989149)

  • 41. Absence of significant interaction of fluconazole with cyclosporin.
    Krüger HU; Schuler U; Zimmermann R; Ehninger G
    J Antimicrob Chemother; 1989 Nov; 24(5):781-6. PubMed ID: 2557319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amelioration of preservation damage but not cyclosporine nephrotoxicity by dihydroergotoxine in kidney transplant recipients. A double-blind placebo-controlled trial.
    Brouwer ML; Wenting GJ; Vincent HH; Hendriks GF; Jeekel J; Weimar W
    Transplantation; 1989 Nov; 48(5):885-6. PubMed ID: 2815264
    [No Abstract]   [Full Text] [Related]  

  • 43. Cyclosporine absorption in two patients with short-bowel syndrome.
    Roberts R; Sketris IS; Abraham I; Givner ML; MacDonald AS
    Drug Intell Clin Pharm; 1988; 22(7-8):570-2. PubMed ID: 3416741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of obesity on cyclosporine disposition.
    Yee GC; Lennon TP; Gmur DJ; Cheney CL; Oeser D; Deeg HJ
    Transplantation; 1988 Mar; 45(3):649-51. PubMed ID: 3279588
    [No Abstract]   [Full Text] [Related]  

  • 45. Interaction of fluconazole with cyclosporin.
    Collignon P; Hurley B; Mitchell D
    Lancet; 1989 Jun; 1(8649):1262. PubMed ID: 2566800
    [No Abstract]   [Full Text] [Related]  

  • 46. Interaction between fluconazole and cyclosporin.
    Collignon P; Hurley B
    Lancet; 1989 Oct; 2(8667):867-8. PubMed ID: 2571795
    [No Abstract]   [Full Text] [Related]  

  • 47. Concomitant administration of cyclosporine and ketoconazole for three and a half years in one heart transplant recipient.
    Girardet RE; Melo JC; Fox MS; Whalen C; Lusk R; Masri ZH; Lansing AM
    Transplantation; 1989 Nov; 48(5):887-90. PubMed ID: 2815266
    [No Abstract]   [Full Text] [Related]  

  • 48. Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine.
    Mallet A; Mentré F; Steimer JL; Lokiec F
    J Pharmacokinet Biopharm; 1988 Jun; 16(3):311-27. PubMed ID: 3065480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of effect of spiramycin on cyclosporin pharmacokinetics.
    Kessler M; Netter P; Renoul HE; Trechot P; Dousset B; Bannwarth B
    Br J Clin Pharmacol; 1990 Mar; 29(3):370-1. PubMed ID: 2360926
    [No Abstract]   [Full Text] [Related]  

  • 50. Norfloxacin-cyclosporine interaction.
    Thomson DJ; Menkis AH; McKenzie FN
    Transplantation; 1988 Aug; 46(2):312-3. PubMed ID: 3043782
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunofluorescence caused by cyclosporine in urinary exfoliative cytology in renal transplant recipients.
    Larsen AE
    Transplantation; 1986 Dec; 42(6):699-702. PubMed ID: 3538556
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclosporine dosing in cystic fibrosis after transplantation.
    Scott JP; Smyth RL; Higenbottam TW; McGoldrick JP; Wallwork J
    Transplantation; 1989 Sep; 48(3):543-4. PubMed ID: 2675421
    [No Abstract]   [Full Text] [Related]  

  • 53. A new cyclosporine formulation.
    Weitman S; Andrews W; Quebbeman E; Whipple J; Ausman R; Schulte W; Adams M
    Transplantation; 1990 Dec; 50(6):1087. PubMed ID: 2256159
    [No Abstract]   [Full Text] [Related]  

  • 54. Neurotoxicity caused by a high cyclosporine metabolite level.
    Kunzendorf U; Brockmöller J; Jochimsen F; Roots I; Offermann G
    Transplantation; 1989 Sep; 48(3):531-2. PubMed ID: 2675417
    [No Abstract]   [Full Text] [Related]  

  • 55. Erythromycin enhances the absorption of cyclosporin.
    Gupta SK; Bakran A; Johnson RW; Rowland M
    Br J Clin Pharmacol; 1988 Mar; 25(3):401-2. PubMed ID: 3282533
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacokinetics of cyclosporine in the weanling pig.
    Freeman DJ; Lipohar C; Kreeft J; Grant DR
    Transplantation; 1990 Nov; 50(5):892-3. PubMed ID: 2238070
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system.
    Kapil RP; Cipriano A; Michels GH; Perrino P; O'Keefe SA; Shet MS; Colucci SV; Noveck RJ; Harris SC
    Clin Drug Investig; 2012 Sep; 32(9):583-92. PubMed ID: 22845044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.
    Venkatakrishnan K; von Moltke LL; Greenblatt DJ
    Clin Pharmacokinet; 2000 Feb; 38(2):111-80. PubMed ID: 10709776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical and economic potential of cyclosporin drug interactions.
    Martin JE; Daoud AJ; Schroeder TJ; First MR
    Pharmacoeconomics; 1999 Apr; 15(4):317-37. PubMed ID: 10537952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacokinetics of fluconazole.
    Debruyne D; Ryckelynck JP
    Clin Pharmacokinet; 1993 Jan; 24(1):10-27. PubMed ID: 8448970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.